Regulatory-grade AI Savana provides multilingual, regulatory-grade, and scientifically validated evidence from real-world clinical data, signaling high relevance for hospitals, regulators, and pharma needing compliant data insights for decision-making and submissions.

Deep Real World Evidence With a focus on deep real-world evidence derived from unstructured health records, Savana presents a compelling data asset for pharma and healthcare organizations pursuing observational studies, market access, and post-market surveillance opportunities.

Enterprise Health Focus Operating in hospitals and health care with a mid-size employee base and demonstrated US expansion, Savana is positioned to partner with hospital systems, health networks, and CROs for large-scale data extraction and analytics projects.

Funding & Growth Recent $25M funding rounds and a track record of Series B growth indicate investor confidence and potential for scale-up collaborations, joint ventures, and expanded product deployment in North America and Europe.

Strategic Partnerships Past collaborations with COPD Foundation and other stakeholders suggest opportunities to co-develop real-world evidence studies, clinical research programs, and data-enabled outcomes research with nonprofits, health systems, and life sciences companies.